Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Rank in Stocks #41525
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Share Price
$0.05646911
Last synced: 2025-05-28
Market Cap
$17.31K
Change (1 day)
-1.67%
Change (1 year)
0.00%
Country
US
Trade LungLife AI, Inc. (LLAI)

Category

Revenue for LungLife AI, Inc. (LLAI)
Revenue in Aug 2026 TTM: 0
According to LungLife AI, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for LungLife AI, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$4.55B -
US
$2.71B -
US